Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Henney pledges FDA cooperation with OAM/ODS on alternative medicine therapies.

This article was originally published in The Tan Sheet

Executive Summary

DSHEA PROVIDES "TOOL" FOR FDA ACTION AGAINST DANGEROUS SUPPLEMENTS, FDA Commissioner-nominee Jane Henney, MD, told the Senate Labor & Human Resources Committee at her confirmation hearing Sept. 2. In response to a question from Sen. Tom Harkin (D-Iowa) on the adequacy of public health protection provided by the Dietary Supplement Health & Education Act, Henney said: "I think Congress in its deliberations tried to strike the right balance in terms of the law that was finally enacted to make dietary supplements available" but also to "give a tool for the FDA to take action when necessary."
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS088819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel